Gout drug colchicine emerges as Covid-19 treatment < Pharma < 기사본문 - KBR - Korea Biomedical Review

Colchicine, commonly used to treat gout, reduced the risk of hospitalizations or death in Covid-19 patients, a study showed. The study results could make colchicine the only oral drug that proved efficacy against Covid-19.
On Saturday, the Montreal Heart Institute (MHI) released the results of the COLCORONA trial conducted on about 4,500 patients worldwide.
The study was a contactless, randomized, double-blind, placebo-controlled trial at the home of non-hospitalized Covid-19 patients in Canada,…

Click here to view the original article.